Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 Study of Autologous MSCs for Drug-Resistant Epilepsy
NCT02497443Phase 2Completed
- Sponsor
- Ministry of Health of Belarus
- Start
- Apr 2011
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in epilepsy, sponsored by Ministry of Health of Belarus. Started Apr 2011; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02497443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497443.